Neuroleptic binding to human brain receptors: relation to clinical effects.

Article Details

Citation

Richelson E

Neuroleptic binding to human brain receptors: relation to clinical effects.

Ann N Y Acad Sci. 1988;537:435-42.

PubMed ID
2904784 [ View in PubMed
]
Abstract

Table 2 summarizes the potential clinical consequences of neurotransmitter receptor blockade by neuroleptics. These pharmacological effects of neuroleptics at receptors in brain and elsewhere in the body are likely responsible for therapeutic and certain adverse effects as well as some drug-drug interactions. Data presented here should allow the physician a rational basis for selecting neuroleptics to minimize these unwanted effects in patients.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
Chlorpromazine5-hydroxytryptamine receptor 2CKi (nM)1.4N/AN/ADetails
ChlorpromazineHistamine H1 receptorKi (nM)9.09N/AN/ADetails
Clozapine5-hydroxytryptamine receptor 2CKi (nM)1.58N/AN/ADetails
ClozapineAlpha-2A adrenergic receptorKi (nM)161.29N/AN/ADetails
ClozapineHistamine H1 receptorKi (nM)2.77N/AN/ADetails
ClozapineMuscarinic acetylcholine receptor M2Ki (nM)12.04N/AN/ADetails
DiphenhydramineHistamine H1 receptorKi (nM)14.08N/AN/ADetails
Fluphenazine5-hydroxytryptamine receptor 2CKi (nM)188.67N/AN/ADetails
Loxapine5-hydroxytryptamine receptor 2CKi (nM)1.69N/AN/ADetails
LoxapineAlpha-2A adrenergic receptorKi (nM)2380.95N/AN/ADetails
LoxapineHistamine H1 receptorKi (nM)5N/AN/ADetails
LoxapineMuscarinic acetylcholine receptor M2Ki (nM)454.54N/AN/ADetails
Methysergide5-hydroxytryptamine receptor 2CKi (nM)6.66N/AN/ADetails
Promazine5-hydroxytryptamine receptor 2CKi (nM)15.87N/AN/ADetails
PromazineHistamine H1 receptorKi (nM)2N/AN/ADetails